|
|
Volumn 13, Issue 4, 2001, Pages 192-199
|
|
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at-home clinical trial
a
|
|
Author keywords
Clinical trial; Drug therapy; Erectile dysfunction; IIEF; Impotence; Oral therapy; PDE5; Phosphodiesterase inhibitor
|
|
Indexed keywords
PHOSPHODIESTERASE INHIBITOR;
PLACEBO;
UNCLASSIFIED DRUG;
VARDENAFIL;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SELECTIVITY;
DYSPEPSIA;
ENZYME INHIBITION;
ERECTILE DYSFUNCTION;
HEADACHE;
HUMAN;
IMPOTENCE;
MAJOR CLINICAL STUDY;
MALE;
MALE SEXUAL DYSFUNCTION;
MULTICENTER STUDY;
PATIENT SATISFACTION;
PENIS ERECTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS;
SEXUAL INTERCOURSE;
TREATMENT OUTCOME;
ADULT;
COITUS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
HUMANS;
IMIDAZOLES;
IMPOTENCE;
MALE;
MIDDLE AGED;
PENILE ERECTION;
PHOSPHODIESTERASE INHIBITORS;
PIPERAZINES;
SAFETY;
SULFONES;
TRIAZINES;
|
|
EID: 0034868820
PISSN: 09559930
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.ijir.3900713 Document Type: Article |
|
Times cited : (305)
|
|
References (30)
|
